Cargando…
Clinical Utility of Cxbladder for the Diagnosis of Urothelial Carcinoma
INTRODUCTION: This study aimed to demonstrate the clinical utility of non-invasive multigene Cxbladder urine tests in reducing the overall number of diagnostic tests and invasive procedures used in the clinical evaluation of patients presenting with microhematuria, a key symptom of urothelial carcin...
Autores principales: | Darling, David, Luxmanan, Carthika, O’Sullivan, Paul, Lough, Tony, Suttie, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427134/ https://www.ncbi.nlm.nih.gov/pubmed/28341930 http://dx.doi.org/10.1007/s12325-017-0518-7 |
Ejemplares similares
-
Clinical Utility of Cxbladder Monitor for Patients with a History of Urothelial Carcinoma: A Physician–Patient Real-World Clinical Data Analysis
por: Lough, Tony, et al.
Publicado: (2018) -
Clinical utility of a non-invasive urine test for risk assessing patients with no obvious benign cause of hematuria: a physician-patient real world data analysis
por: Lough, Tony, et al.
Publicado: (2018) -
A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets
por: Breen, Vivienne, et al.
Publicado: (2015) -
The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma
por: Raman, Jay D., et al.
Publicado: (2021) -
A segregation index combining phenotypic (clinical characteristics) and genotypic (gene expression) biomarkers from a urine sample to triage out patients presenting with hematuria who have a low probability of urothelial carcinoma
por: Kavalieris, Laimonis, et al.
Publicado: (2015)